GEN recently published a list of the top 10 Wall Street Winners of 2013–the ten best stock performers of the year in biotech, pharma, tools/tech, and services (CROs). Which of the companies on our list do you think is most likely to remain victorious on Wall Street?

Poll Question:
Which of our Top 10 Wall Street Winners of 2013 do you think is most likely to keep increasing in value?

Acadia Pharmaceuticals
26

BioCryst Pharmaceuticals
9

Catalyst Pharmaceutical Partners
8

Galectin Therapeutics
10

Gentium
11

Idera Pharmaceuticals
9

Insys Therapeutics
9

Keryx Biopharmaceuticals
5

Prothena
6

Puma Biotechnology
13